FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to biologically active peptides capable to reduce death rate caused by acute blood loss. The application of octapeptide H-Phe-Nle-Phe-Gln-Gly-Gln-Arg-Phe-NH2 (I) amide and its pharmaceutically acceptable salts as an agent for increasing survival rate after acute blood loss.
EFFECT: peptide described above effectively increases survival rate after acute blood loss.
1 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OCTAPEPTIDE AMIDE, CAPABLE OF RAISING BLOOD PRESSURE AND CARDIAC RATE | 2007 |
|
RU2346001C1 |
| METHOD OF SEVERE HEMORRHAGE SHOCK TREATMENT | 1992 |
|
RU2092181C1 |
| THERAPEUTIC GUIDANCE AND/OR MONITORING THERAPY FOR TREATING SHOCK | 2020 |
|
RU2835616C1 |
| DPP3 FOR IMPLEMENTATION, MONITORING AND STRATIFICATION OF THERAPY WITH NT-ADM ANTIBODIES IN PATIENTS WITH SHOCK | 2021 |
|
RU2838370C1 |
| THERAPY MONITORING IN TREATMENT WITH BINDING AGENT AGAINST ADRENOMEDULLIN (ADM) | 2018 |
|
RU2776811C2 |
| PEPTIDE GLP-2 AGONISTS | 2010 |
|
RU2551977C2 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| LONG-ACTING CO-AGONISTS OF GLUCAGON AND GLP-1 RECEPTORS | 2018 |
|
RU2779314C2 |
| PARATHYROID HORMONE ANALOGUES FOR OSTEOPOROSIS TREATMENT | 1997 |
|
RU2203286C2 |
| SLIGHTLY SOLUBLE RELEASING HORMONE-LUTEONIZING HORMONE ANALOG SALT, SLIGHTLY SOLUBLE BOMBESINE ANALOG SALT, PHARMACEUTICAL COMPOSITION, MEDICINAL PREPARATION | 1994 |
|
RU2152222C1 |
